The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in
2004. The guidelines presented here have been updated and extended to reflect …

Objectives C-reactive protein (CRP) and procalcitonin (PCT) are widely used biomarkers in
high-income countries. However, evidence for their use in low-and middle-income countries …

This review was undertaken to determine the role of surgery in the treatment of brucella
endocarditis. All English and French articles reporting brucella endocarditis (1966 to 2011) …

Although vascular pathologies such as vasculitis, endocarditis and mycotic aneurysms have
been described in brucellosis patients, the interaction of Brucella with the endothelium has …

Brucella is an intracellular pathogen responsible of a zoonotic disease called brucellosis.
Brucella survives and proliferates within several types of phagocytic and non‐phagocytic …

Brucella species (Brucellosis) - Infectious Disease and Antimicrobial Agents Microbes Microbes
Home Editorial Board Reviews Contact Us Search Brucella species (Brucellosis) Authors …

Infective endocarditis is a severe disease with high mortality. Despite a global trend towards
an increase in staphylococcal aetiologies, in older patients and a decrease in viridans …

Introduction: Brucellosis is a zoonosis caused by Brucella, a highly infectious Gram-negative
coccobacillus that has been isolated from a variety of mammals. Brucella melitensis is …

Objective To analyze the clinical characteristics of Brucella endocarditis (BE) and observe
the factors related to death to provide guidance for clinical treatment. Methods This study …

Three virulent species of Brucella are currently listed as biological select agent and toxins
(BSAT) in the United States. During recent biannual reviews of listed agents and toxins …